Influenza and pneumonia caused around 12.3 deaths in the U.S. per 100,000 population in 2019. Influenza and pneumonia are among the leading causes of death in the United States, accounting for around 1.6 percent of all deaths in 2020. Influenza, or the flu, is a viral infection that is highly contagious and especially common in the winter season. Influenza is a common cause of pneumonia, although most cases of the flu do not develop into pneumonia. Pneumonia is an infection or inflammation of the lungs and is particularly deadly among young children and the elderly.

Influenza cases

Influenza is very common in the United States, with an estimated 35 million cases reported in 2019-2020. Common symptoms of the flu include cough, fever, runny or stuffy nose, sore throat and headache. Symptoms can be mild but can also be severe enough to require medical attention. In 2019-2020, there were around 16 million influenza-related medical visits in the United States.

Prevention

To prevent contracting the flu people can take everyday precautions such as regularly washing their hands and avoiding those who are sick, but the best way to prevent the flu is by receiving the flu vaccination every year. Receiving a flu vaccination is especially important for young children and the elderly as they are most susceptible to flu complications and associated death. In 2021, around 75 percent of those aged 65 years and older received a flu vaccine, while only 38 percent of those aged 18 to 49 years had done so.

Over 12 million people in the United States died from all causes between the beginning of January 2020 and August 21, 2023. Over 1.1 million of those deaths were with confirmed or presumed COVID-19.

Vaccine rollout in the United States Finding a safe and effective COVID-19 vaccine was an urgent health priority since the very start of the pandemic. In the United States, the first two vaccines were authorized and recommended for use in December 2020. One has been developed by Massachusetts-based biotech company Moderna, and the number of Moderna COVID-19 vaccines administered in the U.S. was over 250 million. Moderna has also said that its vaccine is effective against the coronavirus variants first identified in the UK and South Africa.

This statistic shows the deaths with pneumonia as an underlying cause in England and Wales in 2023, by age and gender. In this year, pneumonia was the underlying cause of over 4.6 thousand deaths for women aged 90 years and older.

No description provided

Legacy unique identifier: P00598

Deaths counts for influenza, pneumonia, and COVID-19 reported to NCHS by week ending date, by state and HHS region, and age group.

In 2020, approximately ** men and ** women per 100,000 population died as a result of pneumonia in England and Wales. In every year in the provided time interval the mortality rate was higher among men, although both genders have experienced a general decline in deaths from pneumonia. Regionally, the North West had the highest mortality rate for both genders.

Pneumonia risk groups

The age groups most at risk from pneumonia is undoubtedly the older age groups. In 2021, in England and Wales, pneumonia was the cause of death for approximately *** thousand over ** year olds, of which *** thousand were women. Furthermore, around *** thousand individuals aged between 80 and 89 years lost their lives due to pneumonia in 2021.

Prevalence of other lung diseases

In England and Wales in 2019, the mortality rate from bronchitis for men was around ** per 100,000 population, while the rate for women was approximately **. The mortality rate for bronchitis was higher than pneumonia, this is caused in part by the large decline in the mortality rate of pneumonia since the year 2000.

In Ireland, there were *** deaths from pneumonia in 2023, a slight increase compared to the previous year. This statistic displays the number of deaths due to pneumonia in Ireland between 2009 and 2023. Respiratory disease in Ireland Pneumonia is a potentially deadly, acute respiratory condition involving lung tissue inflammation often caused by a bacterial, fungal, or viral infection. Other serious respiratory conditions include chronic illnesses such as chronic obstructive pulmonary disease (COPD), emphysema, and asthma. Over recent years, deaths due to diseases of the respiratory system had been increasing in Ireland up until 2018, to decrease in the following years and increase again in 2022. In 2023, there were ***** deaths due to chronic diseases of the lower respiratory system. Other leading health conditions of concern in Ireland include high blood pressure, arthritis, and high cholesterol. Prevention and intervention One major risk factor for both chronic and acute respiratory conditions is smoking: in Ireland, an estimated ** percent of the adult population smokes cigarettes as of 2020. Other risk factors for chronic respiratory conditions include air pollution, exposure to occupational chemicals, and frequent respiratory infections during childhood. Besides avoidance of risk factors and triggers, management of these conditions can be provided through medications such as inhaled corticosteroids.

In 2022, the highest death rate from influenza and pneumonia in Canada per 100,000 population was reported among those aged 90 years and older, with around *** deaths. Individuals between 85 and 89 years followed, with a mortality rate from influenza and pneumonia of almost *** deaths per 100,000 people. This statistic displays the death rate from influenza and pneumonia per 100,000 population in Canada during 2022, by age.

Deaths from pneumonia. Directly age-Standardised Rates (DSR) per 100,000 population Source: Office for National Statistics (ONS) Publisher: Information Centre (IC) - Clinical and Health Outcomes Knowledge Base Geographies: Local Authority District (LAD), Government Office Region (GOR), National, Strategic Health Authority (SHA) Geographic coverage: England Time coverage: 2005-07, 2007 Type of data: Administrative data

Provisional counts of the number of death occurrences in England and Wales due to coronavirus (COVID-19) and influenza and pneumonia, by age, sex and place of death.

TABLE III. Deaths in 122 U.S. cities – 2016. 122 Cities Mortality Reporting System — Each week, the vital statistics offices of 122 cities across the United States report the total number of death certificates processed and the number of those for which pneumonia or influenza was listed as the underlying or contributing cause of death by age group (Under 28 days, 28 days –1 year, 1-14 years, 15-24 years, 25-44 years, 45-64 years, 65-74 years, 75-84 years, and ≥ 85 years).

FOOTNOTE: U: Unavailable. —: No reported cases. * Mortality data in this table are voluntarily reported from 122 cities in the United States, most of which have populations of 100,000 or more. A death is reported by the place of its occurrence and by the week that the death certificate was filed. Fetal deaths are not included.

† Pneumonia and influenza.

§ Total includes unknown ages.

This dataset tracks the updates made on the dataset "Deaths from Pneumonia and Influenza (P&I) and all deaths, by state and region, National Center For Health Statistics Mortality Surveillance System" as a repository for previous versions of the data and metadata.

Statistical information on confirmed cases and deaths of severe special infectious pneumonia starting in 2020, with secondary statistical tables stratified by region, age group, and gender. This data set is updated once a day according to the system's fixed schedule. At present, there are more cases of severe special infectious pneumonia imported from overseas than those confirmed by tests at airports or centralized quarantine stations and immediately isolated and treated, so their county and city information is not marked.

🇺🇸 미국

This statistic shows the number of deaths from pneumonia in Taiwan in 2023, by age group. That year, ** infants younger than *** year died from pneumonia in Taiwan, whereas ***** children between *** and 14 years old were victims of pneumonia. The largest share of patients who died from the disease were senior citizens aged 65 and above.

In the early 1980s, Nepal’s children suffered from some of the highest death rates from pneumonia in the world, with over 1,400 deaths for every 100,000 children under five. That meant around 39,000 children died from pneumonia each year, more than from any other cause.

Since then, Nepal has made huge progress. The death rate has fallen almost 20-fold. This improvement is due to various measures, including pneumococcal and Hib vaccines, better access to healthcare and antibiotics, and improved nutrition.

Despite this progress, pneumonia is still among the leading causes of death in children in Nepal. And we know that more progress can be made: high-income countries have achieved much lower rates, with fewer than 5 per 100,000.

The total number of deaths caused by pneumonia in Japan amounted to approximately ***** thousand cases in 2023, continuing a general downward trend since 2014. Pneumonia is one of the main causes of death in Japan.

Post-neonatal pneumonia number of deaths and mortality rates for the WHO regions (PN: Pneumonia; 95% CI: 95% Confidence Interval; WHO: World Health Organisation).